Isoflavones Market Size & Share 2023 to 2032
Market Size by Source [Soy (Food & beverages, Nutraceuticals, Cosmetics), Chickpea (Food & beverages, Nutraceuticals, Cosmetics), Red Clover (Food & beverages, Nutraceuticals, Cosmetics)].
Report ID: GMI3077
|
Published Date: March 2023
|
Report Format: PDF
Download Free PDF
Authors:
Kiran Pulidindi, Kunal Ahuja
Isoflavones Market Size
Isoflavones Market size valued at USD 16.5 billion in 2022 and is projected to expand at over 5% CAGR from 2023 to 2032.
Isoflavones Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
The rapidly growing health-conscious population, particularly across the North American region is expected to have a positive impact on the industry growth. In the recent past, a large portion of the Western populace has turned obese or overweight due to the rising acceptance of unhealthy dietary habits and lifestyle preferences. As per the State of Obesity 2022 report published by the Trust for America’s Health (TFAH) in September 2022, four in ten U.S. adults are obese. Obesity is a growing burden on the U.S. healthcare resulting in an estimated surge in spending by USD 170 billion. Hence, the rising focus on weight management and the growing emphasis on health and fitness is expected to prompt individuals to adopt healthier dietary lifestyles.
Isoflavones Market Trends
High risk of health complications, such as Kawasaki disease (KD) related to the long-term consumption of large amounts of soy products is expected to hamper the isoflavones market demand. Soy isoflavones can be difficult to digest and can cause constipation, diarrhea, and other digestive problems. Additionally, isoflavones are also considered for reacting with certain treatments for conditions such as cystic fibrosis, kidney stones, and hyperthyroidism. The compound is also known to have certain side effects on female reproductive health with abnormal tissue growth in the uterus, and poor development of the reproductive system in case of long-term exposure to isoflavone genistein.
Isoflavones Market Analysis
The isoflavones market share from nutraceutical applications segment surpassed USD 7 billion in 2022, attributed to the increasing consumer inclination toward health and wellness. Nutraceutical supplements have gained substantial momentum over the past few years as they offer a myriad of health benefits. They have proven to help prevent and treat illnesses associated with neurodegeneration, heart, and diseases caused due to oxidative stress. Nutraceuticals also have a promising impact on lifestyle disorders such as hypertension, cancer, and diabetes. Furthermore, several governments are launching innovative efforts to boost rural access to affordable nutraceuticals. For instance, in March 2022, the Indian government announced the provision of nutraceuticals across 8,000 government-operated medical retail stores to provide medications at 50% to 90% lower prices compared to branded medicines.
The soy isoflavones market will reach USD 26 billion by 2032. The emergence of new trends, such as vegan diets have propelled the consumer inclination toward the consumption of soy-based and plant protein ingredients. The growing awareness regarding the adverse impact of meat consumption has encouraged people to switch to plant-based proteins. Several manufacturers are thus ramping up efforts to boost the production of soy protein ingredients to address the growing consumer demand. For instance, in August 2022, Archer Daniels Midland (ADM) partnered with Benson Hill, a food tech company, to accelerate its ultra-high protein (UHP) soy portfolio while meeting the growing demand for plant-based protein in North America.
North America isoflavones market size is anticipated to record 4.8% CAGR through 2032. The region is expected to emerge as a lucrative hub for isoflavone producers with rapidly changing consumer preferences, the rising popularity of veganism, and the growing demand for plant-based proteins. Countries such as the U.S., and Canada have witnessed dramatic shift in consumer preference for plant-based dairy products from conventional dairy. Regional consumers are switching to dairy-free alternatives such as soy milk due to the rising prevalence of dairy allergies. Hence, this thriving demand has spurred soy production across the continent, offering lucrative scope for industry expansion. For instance, as per the Crop Production report released by the National Agricultural Statistics Service (NASS) of the USDA in August 2022, soybean growers set a 2% growth in production from 2021, estimated at 4.53 billion bushels.
Isoflavones Market Share
Some of the leading companies in the isoflavones market include:
These firms are focusing on innovations and R&D activities to strengthen their business footprint. For instance, in March 2023, ADM entered a joint venture agreement with Marel to establish an innovation center in the Netherlands with an aim of accelerating the need for alternative protein capabilities.
Impact of COVID-19 Pandemic
The COVID-19 pandemic introduced novel challenges and opportunities for isoflavone manufacturers. With the massive supply chain disruptions and imposition of lockdowns by several governments, isoflavone producers struggled to maintain their manufacturing output due to the temporary shutdown of facilities. However, the pandemic-driven shift in consumer preference for the consumption of dietary supplements and immunity boosters fostered lucrative scope for novel isoflavone-based products. Moreover, the increasing emphasis on preventative care and the rising number of health-conscious consumers complimented the industry outlook.
This isoflavones market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilotons and revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Source
The above information has been provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →